<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="utf-8">
    <!-- Responsive -->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0">

    <title>OtiTopic</title>

    <link rel="shortcut icon" type="image/x-icon" href="img/favicon.png" />
    <!-- Google Font -->
    <link href="https://fonts.googleapis.com/css?family=Nunito:300,400,600,700&display=swap" rel="stylesheet">

    <!-- css styles -->
    <link rel="stylesheet" href="css/owl.carousel.min.css" />
    <link rel="stylesheet" href="css/owl.theme.default.min.css" />
    <link rel="stylesheet" href="css/icofont.min.css" />
    <link rel="stylesheet" href="css/bootstrap.min.css" />
    <link rel="stylesheet" href="css/style.css" />

</head>

<body>

    <!-- Start Pre-loader -->
    <div class="pre-loader-wrap">
        <div class="pre-loader triangle">
            <svg viewBox="0 0 86 80">
                <polygon points="43 8 79 72 7 72"></polygon>
            </svg>
            <span>Loading...</span>
        </div>
    </div>
    <!-- End Pre-loader -->

    <!-- Start header section -->
    <section class="header-section research-banner">
        <header class="header-area">
            <div class="dope-nav-container breakpoint-off">
                <div class="container">
                    <div class="row">
                        <!-- Main Menu -->
                        <nav class="dope-navbar justify-content-between" id="dopeNav">

                            <!-- Logo -->
                            <a class="nav-brand" href="index.html"><img src="img/otitopic-logo-header.svg" alt=""></a>

                            <!-- Navbar Toggler -->
                            <div class="dope-navbar-toggler">
                                <span class="navbarToggler"><span></span><span></span><span></span></span>
                            </div>

                            <!-- Menu -->
                            <div class="dope-menu">
                                <!-- close btn -->
                                <div class="dopecloseIcon">
                                    <div class="cross-wrap"><span class="top"></span><span class="bottom"></span></div>
                                </div>

                                <!-- Nav Start -->
                                <div class="dopenav">
                                    <ul id="nav">
                                        <li><a href="index.html">Home</a></li>
                                        <li><a href="about-us.html">About Us</a></li>
                                        <li><a href="therapies.html">Therapies</a></li>
                                        <li><a href="research.html" class="active">Research</a></li>
                                        <li><a href="technology.html">Technology</a></li>
                                        <li><a href="investors.html">Investors</a></li>
                                        <li><a href="careers.html">Careers</a></li>
                                        <li><a href="contact-us.html">Contact</a></li>
                                    </ul>
                                </div>
                                <!-- Nav End -->
                            </div>
                        </nav>

                        <!-- Start Nav Overlay -->
                        <div class="overlay"></div>
                        <!-- End Nav Overlay -->

                    </div>
                </div>
            </div>
        </header>

    </section>
    <!-- End header section -->

    <!-- Start Main Page Wrapper -->
    <main>

        <!-- Start Header Banner -->
        <section class="otitopic-header-info">
            <div class="container">
                <div class="row">
                    <div class="col-lg-6">
                         <div class="banner-tag-head">
                            <h2>Research</h2>
                            <ul>
                                <li>We are a privately funded drug development company with a track record of success in biopharmaceutical product development.</li>
                            </ul>
                        </div>
                    </div>
                    <div class="col-md-6">
                        <ul class="breadcrumbs">
                          <li><a href="" class="inactive">Home</a></li>
                          <li><a href="" class="active">Research</a></li>
                        </ul>
                    </div>
                </div>
            </div>
        </section>
        <!-- End Header Banner -->

        <!-- Start myocardial infarction section -->
        <section class="myocardial-infarction-section section-gap section-gap-top section-gap-bottom">
            <div class="container">
                <div class="justify-content-between align-items-center col-md-myocardial">
                    <div class="text-center img-wrap">

                        <div class="ugb-video-popup" style="background: url('img/myocardial-img.jpg') no-repeat;">
                       
                            <div class="ugb-video-wrapper">
                                <a href="#" data-toggle="modal" data-target="#about-otitopic-video">
                                    <span class="ugb-play-button">
                                        <svg xmlns="http://www.w3.org/2000/svg" width="70" height="70" viewBox="0 0 34 34"><path d="M17 34C7.6 34 0 26.4 0 17S7.6 0 17 0s17 7.6 17 17-7.6 17-17 17zm0-32C8.7 2 2 8.7 2 17s6.7 15 15 15 15-6.7 15-15S25.3 2 17 2z"/><path d="M12 25.7V8.3L27 17l-15 8.7zm2-14v10.5l9-5.3-9-5.2z"/></svg>
                                    </span>
                                </a>
                            </div>

                            <!-- Modal Video for About Otitopic -->
                            <div class="modal fade" id="about-otitopic-video" tabindex="-1" role="dialog" aria-labelledby="exampleModalCenterTitle" aria-hidden="true">
                                <div class="modal-dialog modal-lg modal-dialog-centered" role="document">
                                    <div class="modal-content">
                                        <video width="100%" height="100%" controls>
                                            <source src="img/videos/iStock-469473726.mp4" type="video/mp4">
                                        </video>
                                    </div>
                                </div>
                            </div>

                        </div>
                    </div>
                    <div class="text-wrap-myocardial">
                        <h2>A New Era in Myocardial Infarction Management</h2>
                        <br>
                        <p>In 2019, Otitopic completed a dose range study. Asprihale® reaches peak plasma concentration in two
                        minutes versus 20 minutes for 162 mg non-enteric coated chewable aspirin. This rapid exposure is
                        unprecedented and has enormous implications for early disruption of an evolving thrombus, where
                        differences in time of restoration of blood flow within minutes with different therapies can be life-
                        altering. The very high levels of serum thromboxane B 2 (TxB 2 ) suppression, and complete inhibition of
                        arachidonic acid (AA)-induced platelet aggregation, both within two minutes, are unprecedented for a
                        non-parenterally administered antiplatelet therapy.</p>
                    </div>
                </div>
            </div>
       
            <div class="info-section mt-50">
                <div class="container-fluid">
                    <div class="row d-flex align-items-center col-md-rev">
                        <div class="col-lg-12 col-md-12 info-left">
                            <div class="info-left-wrap">
                                <ul class="grid-container-flex-two">
                                    <li>
                                        <div class="list-number"><img src="img/icons/microscope.png" alt="icon"></div>
                                        <div class="details">
                                            <p>Asprihale® aspirin exposure occurred more rapidly compared to chewed aspirin</p>
                                        </div>
                                    </li>
                                    <li>
                                        <div class="list-number"><img src="img/icons/microscope.png" alt="icon"></div>
                                        <div class="details">
                                            <p>With respect to Asprihale® PK, there is a 1.6-fold greater C max of aspirin when inhaled, which is similar to IV administration</p>
                                        </div>
                                    </li>
                                    <li>
                                        <div class="list-number"><img src="img/icons/microscope.png" alt="icon"></div>
                                        <div class="details">
                                            <p>Asprihale® early and consistent reduction in TxB 2 led to early and consistent suppression of platelet aggregation by AA in two minutes</p>
                                        </div>
                                    </li>
                                    <li>
                                        <div class="list-number"><img src="img/icons/microscope.png" alt="icon"></div>
                                        <div class="details">
                                            <p>The immediate antiplatelet and inhibitory effects of Asprihale® would be expected to translate to meaningful clinical benefits in the early evolution of arterial thrombosis</p>
                                        </div>
                                    </li>
                                    <li>
                                        <div class="list-number"><img src="img/icons/microscope.png" alt="icon"></div>
                                        <div class="details">
                                            <p>Decreased interpatient variability of TxB2 inhibition and AA-induced platelet aggregation when aspirin is administered by the inhaled route of administration</p>
                                        </div>
                                    </li>
                                    <li>
                                        <div class="list-number"><img src="img/icons/microscope.png" alt="icon"></div>
                                        <div class="details">
                                            <p>The individual data for both AA-induced platelet aggregation and TxB2 inhibition show more rapid and consistent response in two minutes than chewable aspirin</p>
                                        </div>
                                    </li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
       
            <div class="otitopic-research-tech-trials-section mt-100">
                <div class="container">

                    <div class="justify-content-between align-items-center col-md-rev-otitopic-research">
                        <div class="text-wrap">
                            <h2>Otitopic Research</h2>
                            
                            <div class="col-grid-text">
                                <p>Otitopic’s proprietary formulation contains particles engineered to produce an aerodynamic profile that results in maximum deep lung delivery. The aerodynamic profile is a result of the interaction between the inhaler and the formulation’s properties such as particle size and density. Otitopic has evaluated countless formulations and devices to ensure that patients will receive an optimal therapy for management of suspected acute MI.</p>
                                
                                <p>The current formulation has undergone design of experiment studies to prepare for validation of the commercial manufacturing process. Most analytical methods have passed Phase III validation to support sale and marketing of Asprihale® in the US. Otitopic has been issued multiple patents and is the only company that can market orally inhaled dry powder aspirin worldwide.</p>
                            </div>
                        </div>
                    </div>

                    <div class="justify-content-between align-items-center col-md-rev">
                        <div class="text-wrap">
                            <h2>Technology</h2>
                            <br>
                            <p>The interaction between our capsule-based DPI and proprietary formulation creates an ideal aerodynamic profile that allows for deep lung delivery of the active ingredient. Asprihale® is easy to use and is delivered into the bloodstream in less than two minutes.</p>
                            <a href="" class="btn-outline">Learn more</a>
                        </div>
                        <div class="text-center img-wrap">
                            <img class="img-fluid" src="img/technology.jpg" alt="">
                        </div>
                    </div>

                    <div class="justify-content-between align-items-center col-md-rev-trials mt-50">
                        <div class="text-center img-wrap">
                            <img class="img-fluid" src="img/lungs-img.jpg" alt="">
                        </div>
                        <div class="text-wrap-trials">
                            <h2>Clinical Trials</h2>
                            <br>
                            <p>Asprihale® is a 505(b)(2) project. FDA has agreed that an accelerated clinical plan would be sufficient to bring the drug to market. Otitopic has completed a dose range study and is preparing for a randomized pivotal PK/PD study to establish bioequivalence.</p>

                            <div class="justify-content-between align-items-center col-md-clinical-trials-grid">
                                <div class="card-wrap">
                                    <p>Asprihale® completely inhibits AA-induced platelet aggregation within two minutes versus 30 minutes for chewable aspirin.</p>
                                </div>

                                <div class="card-wrap mt-30">
                                    <p>Inhibition of TxB2 in the first 20 minutes was greater in the Asprihale® group.</p>
                                </div>
                            </div>

                        </div>
                    </div>
                </div>
            </div>
        </section>
        <!-- End therapies section -->

        <!-- Start testimonials section -->
        <section class="testimonials-section section-gap-top section-gap-bottom">
            <div class="container">
                <div class="row justify-content-center d-flex">
                    <div class="col-lg-10 gallery-wrap">
                        <div class="outer">
                            <div id="big" class="owl-carousel owl-theme portfolio-carousel">
                                <div class="item">
                                    <img src="img/icons/quote.svg" alt="quote">
                                    <h2>OTI-0726 would certainly have a meaningful clinical effect in patients. If you look at the underlying pathology, the longer the clotting process has progressed, the more stable the clot becomes. Attacking the clot earlier could abort or dampen the thrombotic process.</h2>

                                    <div class="author">
                                        <div class="line-separator">
                                            <img src="img/icons/line.png" alt="line icon">
                                        </div>
                                        <div>
                                            <h4>Interventional Cardiologist</h4>
                                            <p>Major Academic Medical Center</p>
                                        </div>
                                    </div>

                                </div>
                                <div class="item">
                                    <img src="img/icons/quote.svg" alt="quote">
                                    <h2>I am not perfectly systematic when it comes to recommending rescue aspirin to my patients. When aspirin comes up in conversation, I will mention that a rescue aspirin is a good idea in the event of a heart attack. Since the guideline update my patients and I have been discussing aspirin more often</h2>

                                    <div class="author">
                                        <div class="line-separator">
                                            <img src="img/icons/line.png" alt="line icon">
                                        </div>
                                        <div>
                                            <h4>Cardiologist KOL</h4>
                                            <p>Harbor-UCLA Medical Center</p>
                                        </div>
                                    </div>
                                    
                                </div>
                                <div class="item">
                                    <img src="img/icons/quote.svg" alt="quote">
                                    <h2>The major strength of this product is that it’s anti-platelet effects begin within 2 minutes. Asprihale® would begin inhibiting platelet aggregation much faster than our standard chewable aspirin </h2>

                                    <div class="author">
                                        <div class="line-separator">
                                            <img src="img/icons/line.png" alt="line icon">
                                        </div>
                                        <div>
                                            <h4>ER physician</h4>
                                            <p>WellStar West Georgia Medical Center</p>
                                        </div>
                                    </div>
                                    
                                </div>
                                <div class="item">
                                    <img src="img/icons/quote.svg" alt="quote">
                                    <h2>I don’t need to see outcomes data to believe that this product will help my patients. The chain of logic that connects early aspirin administration and better outcomes to faster platelet inhibition is sufficient for me to prescribe Asprihale®</h2>

                                    <div class="author">
                                        <div class="line-separator">
                                            <img src="img/icons/line.png" alt="line icon">
                                        </div>
                                        <div>
                                            <h4>Cardiology KOL</h4>
                                            <p>Harbor-UCLA Medical Center</p>
                                        </div>
                                    </div>
                                    
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </section>
        <!-- End testimonials section -->
      
        <!-- Start call to action section -->
        <section class="cta-section section-gap-top section-gap-bottom">
            <div class="container">
                <div class="row d-flex align-items-center col-md-rev">
                    <div class="col-lg-9 col-md-12">
                        <h2>Let’s provide you a faster alternative for management of suspected myocardial infarction (MI)</h2>
                        <div class="btn-flex">
                            <a href="contact-us.html" class="btn-outline">Get in touch</a>    
                        </div>
                    </div>
                </div>
            </div>
        </section>
        <!-- End call to action section -->

    </main>
    <!-- End Main Page Wrapper -->

  
    <!-- Start footer section -->
    <footer class="footer-section section-gap-top">
        <div class="container">
            <div class="grid-row-footer footer-top section-gap-bottom">

                <div class="footer-widgets">
                    <img class="footer-logo" src="img/otitopic-logo-footer.svg" alt="">
                    <p class="footer-brand-excerpt">OtiTopic, Inc. is a late-stage pharmaceutical company, with a track record of success in product drug delivery and drug service development.</p>
                    <ul class="social-lists">
                        <li><a href="#" target="__blank"><img src="img/icons/fb.svg"></a></li>
                        <li><a href="#" target="__blank"><img src="img/icons/in.svg"></a></li>
                        <li><a href="#" target="__blank"><img src="img/icons/tw.svg"></a></li>
                        <li><a href="#" target="__blank"><img src="img/icons/yt.svg"></a></li>
                    </ul>
                </div>

                <div class="footer-widgets">
                    <div class="single-widget">
                        <h4 class="wiget-title">Company</h4>
                        <ul class="list-style">
                            <li><a href="#">About us</a></li>
                            <li><a href="#">Careers</a></li>
                            <li><a href="#">Contact Us</a></li>
                            <li><a href="#">Blogs & News</a></li>
                        </ul>
                    </div>
                </div>

                <div class="footer-widgets">
                    <div class="single-widget">
                        <h4 class="wiget-title">Services</h4>
                        <ul class="list-style">
                            <li><a href="#">Our Science</a></li>
                            <li><a href="#">Our Research</a></li>
                            <li><a href="#">Our Pipeline</a></li>
                            <li><a href="#">Our Technologies</a></li>
                            <li><a href="#">Our Therapies</a></li>
                        </ul>
                    </div>
                </div>

                <div class="footer-widgets">
                    <div class="single-widget">
                        <h4 class="wiget-title">Investors</h4>
                        <ul class="list-style">
                            <li><a href="#">Investor Relation</a></li>
                            <li><a href="#">Press Release</a></li>
                            <li><a href="#">Company Presentation</a></li>
                        </ul>
                    </div>
                </div>

            </div>

            <div class="row copyright-bottom d-flex align-items-center">
                <div class="col-md-6">
                    <p>&copy; Copyright OtiTopic <span id="year"></span>. All Rights Reserved.</p>
                </div>
                <div class="col-md-6">
                    <ul>
                        <li><a href="privacy-policy.html">Privacy Policy</a></li>
                        <li><a href="terms-conditions.html">Terms & Conditions</a></li>
                    </ul>
                </div>
            </div>
        </div>
    </footer>
    <!-- End footer section -->

    <!-- Start Scroll Top -->
    <div class="scroll-top">
        <i class="icofont-rounded-up"></i>
    </div>
    <!-- End Scroll Top -->

    <!-- JS Files -->
    <script src="js/jquery-3.3.1.slim.min.js"></script>
    <script src="js/popper.min.js"></script>
    <script src="js/bootstrap.min.js"></script>
    <script src="js/owl.carousel.min.js"></script>
    <script src="js/dopeNav.js"></script>
    <script src="js/main.js"></script>
    <script>document.getElementById("year").innerHTML = new Date().getFullYear();</script>

</body>

</html>